Philip Morris International (PMI) is leading the way in transforming the entire tobacco industry toward a smoke-free future. This involves offering valid smoke-free alternatives to millions of adult smokers, both men and women, who would otherwise continue to smoke cigarettes. The World Health Organization estimates that in 2025 there will be over a billion smokers worldwide, around the same number as today.*
*WHO Global Report on Trends in Prevalence of Tobacco Smoking 2000-2025, 2018.
![16.12.13_PMI Science_Day1_1157 copy](https://www.pmi.com/resources/images/default-source/italy-user/16-12-13_pmi-science_day1_1157-copy.jpg?sfvrsn=3c505fb4_0
)
Scientific method and research
Research and innovation underpin our vision of a smoke-free future. This is why we have invested more than >12.5 billion dollars in research and development (R&D) since 2008. Our R&D activity is carried out according to internationally-recognized protocols, including Good Laboratory Practices and Good Clinical Practices, in order to guarantee quality and transparency throughout. For more information, visit pmiscience.com.
![JPG-1600width-16.12.13_PMI Science_Day1_2374 copy](https://www.pmi.com/resources/images/default-source/italy-user/chi-siamo-_italy/jpg-1600width-16-12-13_pmi-science_day1_2374-copy.jpg?sfvrsn=a57e5fb4_0
)
The Philip Morris team of scientists
For over 15 years, more than 1,586 scientists and engineers (comprising 40 different nationalities and experts in around 30 scientific/engineering areas) have studied the potential value of smoke-free products in our two centers of Research & Development in Singapore and Neuchâtel, Switzerland.
![pmi-scientist-cube-highlight-thumbnail](https://www.pmi.com/resources/images/default-source/global-market-images/breakthrough-products/pmi-scientist-cube-highlight-thumbnail.jpg?sfvrsn=3e9711b4_2
)